![](/img/cover-not-exists.png)
Combining BRAF inhibition with oncolytic herpes simplex virus enhances the immune-mediated antitumor therapy of BRAF-mutant thyroid cancer
Crespo-Rodriguez, Eva, Bergerhoff, Katharina, Bozhanova, Galabina, Foo, Shane, Patin, Emmanuel C, Whittock, Harriet, Buus, Richard, Haider, Syed, Muirhead, Gareth, Thway, Khin, Newbold, Kate, Coffin,Volume:
8
Journal:
Journal for ImmunoTherapy of Cancer
DOI:
10.1136/jitc-2020-000698
Date:
August, 2020
File:
PDF, 1.28 MB
2020